RSRodrigo Pires dos Santos

Rodrigo Pires dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rodrigo Pires dos Santos has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Accuracy of tracheal aspirate gram stain in predicting Staphylococcus aureus infection in ventilator-associated pneumonia

    by Renato Seligman, Beatriz Graeff Santos Seligman, Loriane Konkewicz, Rodrigo Pires dos Santos

    The Gram stain can be used to direct initial empiric antimicrobial therapy when complete culture is not available. This rapid test could prevent the initiation of inappropriate therapy and adverse outcomes. However, several studies have attempted to determine the value of the Gram stain in the diagnosis and therapy of bacterial infection in different populations of patients with ventilator-associated pneumonia (VAP) with conflicting results. The objective of this study is to evaluate the accuracy of the Gram stain in predicting the existence of Staphylococcus aureus infections from cultures of patients suspected of having VAP.


  • Open Access

    Comparison of anti-anaerobic antimicrobial strategies in cancer patients with febrile neutropenia and gastrointestinal symptoms

    by Regis G Rosa, Rodrigo P dos Santos, Luciano Z Goldani

    The current study sought to compare 28-day mortality rates in cancer patients with febrile neutropenia (FN) and gastrointestinal (GI) symptoms who underwent monotherapy using an antibiotic with antipseudomonal and anti-anaerobic activity (piperacillin-tazobactam or a carbapenem) and a group treated with a combination of cefepime-metronidazole. We performed a prospective cohort study in a single tertiary hospital from October 2009 to August 2011. All consecutive adult cancer patients admitted with FN secondary to intensive chemotherapy and GI symptoms (abdominal pain, diarrhea or perianal pain) were evaluated. Kaplan-Meier curves were used for calculating time-dependent occurence of death. In total, 37 patients with FN and GI symptoms were evaluated (15 in monotherapy arm and 22 in the combination therapy arm). Treatment with combination cefepime and metronidazole resulted in a lower 28-day mortality rate compared with piperacillin-tazobactam or carbapenem monotherapy (0% versus 40%; log-rank P=0.002). Results of the present study suggest a significant reduction in mortality in cancer patients with FN and GI symptoms treated with combination cefepime-metronidazole therapy compared with monotherapy using agents with antipseudomonal and anti-anaerobic activity. Further randomized trials are warranted to confirm the superior results using combination therapy in patients with FN and GI symptoms.


  • Open Access

    Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study

    by Regis G Rosa, Luciano Z Goldani, Rodrigo P dos Santos

    Background: Initial management of chemotherapy-induced febrile neutropaenia (FN) comprises empirical therapy with a broad-spectrum antimicrobial. Currently, there is sufficient evidence to indicate which antibiotic regimen should be administered initially. However, no randomized trial has evaluated whether adherence to an antimicrobial stewardship program (ASP) results in lower rates of mortality in this setting. The present study sought to assess the association between adherence to an ASP and mortality among hospitalised cancer patients with FN.Methods: We conducted a prospective cohort study in a single tertiary hospital from October 2009 to August 2011. All adult patients who were admitted to the haematology ward with cancer and FN were followed up for 28 days. ASP adherence to the initial antimicrobial prescription was determined. The mortality rates of patients who were treated with antibiotics according to the ASP protocol were compared with those of patients treated with other antibiotic regimens. The multivariate Cox proportional hazards model and propensity score were used to estimate 28-day mortality risk.Results: A total of 307 FN episodes in 169 subjects were evaluated. The rate of adherence to the ASP was 53%. In a Cox regression analysis, adjusted for propensity scores and other potential confounding factors, ASP adherence was independently associated with lower mortality (hazard ratio, 0.36; 95% confidence interval, 0.14–0.92).Conclusions: Antimicrobial selection is important for the initial management of patients with FN, and adherence to the ASP, which calls for the rational use of antibiotics, was associated with lower mortality rates in this setting.


  • Changes in hand hygiene compliance after a multimodal intervention and seasonality variation

    by Rodrigo Pires dos Santos, Loriane Rita Konkewicz, Fabiano Marcio Nagel, Thiago Lisboa, Renan Cortez Xavier, Thalita Jacoby, Sandra Ludwig Gastal, Nádia Mora Kuplich, Márcia Rosane Pires, Carem Gorniak Lovatto, et al.


  • Open Access

    Antimicrobial Stewardship Lessons: Know When to Say No to Vancomycin

    by R. P. D. Santos, Caroline Deutschendorf, Fabiano Nagel, Loriane Konkewicz, Thiago Lisboa

    To the Editor—O'Horo et al [1] found that negative predictive value of Gram stain for the diagnosis of ventilator-associated pneumonia (VAP) was 91% (for a prevalence between 20% and 30%), suggesting that VAP is unlikely with a negative Gram stain result. Moreover, there was only a fair concordance between organisms on Gram stain and those recovered from culture. However, a remarkable result was the high accordance between Gram stain and culture results for gram-positive organisms. The impact of these later finding on the empirical therapy for gram-positive organisms is worth to be discussed.


  • Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates

    by Rodrigo Pires dos Santos, Thalita Jacoby, Denise Pires Machado, Thiago Lisboa, Sandra Ludwig Gastal, Fabiano Márcio Nagel, Nádia Mora Kuplich, Loriane Konkewicz, Carem Gorniak Lovatto, Márcia Rosane Pires, et al.

    Objective.: To evaluate the impact of ertapenem use in Pseudomonas aeruginosa carbapenem resistance, taking into account the volume of antimicrobial consumption, the consumption by the entire hospital of alcohol-based antiseptic hand rub, and the density rate of invasive practices.Design.: Before-and-after trial.Setting.: A tertiary care university hospital in southern Brazil.Methods.: Ertapenem was first added to the hospital formulary in June 2006, and it was excluded in February 2009. We evaluated Pseudomonas aeruginosa resistance rates through 3 study periods: period 1, before ertapenem use (17 months); period 2, during ertapenem use (33 months); and period 3, after exclusion of ertapenem (15 months).Results.: After introduction of ertapenem, there was a significant decrease in median consumption of imipenem or meropenem, from 2.6 to 2.2 defined daily doses (DDDs) per 100 patient-days (level change from 0.04 to -1.08; P < .01), and an increase in the use of these medications after ertapenem exclusion, from 2.2 to 3.3 DDDs per 100 patient-days (level change from -0.14 to 0.91; P < .01), by segmented regression analysis. There was no difference in the incidence density of carbapenem-resistant P. aeruginosa infection related to ertapenem use throughout the study periods. However, by multiple regression analysis, the reduction in the rate of carbapenem-resistant P. aeruginosa infection correlated significantly with the increase in the volume of alcohol used as hand sanitizer, which was from 660.7 mL per 100 patient-days in period 1 to 2,955.1 mL per 100 patient-days in period 3 (P = .04). Ertapenem use did not impact the rate of carbapenem-resistant P. aeruginosa infection.Conclusions.: Use of alcohol-based hand gel, rather than ertapenem, was associated with a reduction in the rates of carbapenem-resistant P. aeruginosa infection. Measures to reduce resistance must include factors other than just antimicrobial stewardship programs alone.


  • Open Access

    In-Hospital Mortality of Disseminated Tuberculosis in Patients Infected with the Human Immunodeficiency Virus

    by Rodrigo Pires dos Santos, Caroline Deutschendorf, Karin Scheid, Luciano Zubaran Goldani

    Background. Tuberculosis (TB) is a cause of significant morbidity and mortality in patients with AIDS. The goal of our study was to determine predictors of in-hospital mortality in patients with AIDS and disseminated tuberculosis in a middle-income country.Material and Methods. We conducted a retrospective cohort study in a tertiary care center, for patients with AIDS in southern Brazil. From 1996 to 2008, all patients with the diagnosis of disseminated TB were included.Results. Eighty patients were included. In-hospital mortality was 35% (N=28). On multivariate Cox regression analysis, low basal albumin(P<.01)was associated with death, and fever at admission was related to better survival(P<.01).Conclusion. Albumin levels or fever are independent predictors of survival in patients with HIV and disseminated TB. They can serve as indirect markers of immunodeficiency in patients with disseminated TB and AIDS.


  • The 2009 H1N1 Influenza A Pandemic and Hand Hygiene Practices in a Hospital in the South of Brazil

    by Rodrigo Pires dos Santos, Loriane Rita Konkewicz, Fabiano Nagel, Thiago Lisboa, Thalita Jacoby, Sandra Ludwig Gastal, Nádia Mora Kuplich, Guilherme Sander, Márcia Pires, Carem Gorniak Lovatto

    The 2009 H1N1 Influenza A Pandemic and Hand Hygiene Practices in a Hospital in the South of Brazil - Volume 31 Issue 12 - Rodrigo Pires dos Santos, Loriane Rita Konkewicz, Fabiano Nagel, Thiago Lisboa, Thalita Jacoby, Sandra Ludwig Gastal, Nádia Mora Kuplich, Guilherme Sander, Márcia Pires, Carem Gorniak Lovatto


  • Disseminated nontuberculous mycobacterial disease in patients with acquired immune deficiency syndrome in the south of Brazil

    by Rodrigo Pires dos Santos, Karin Scheid, Luciano Zubaran Goldani

    A retrospective cohort was studied in order to evaluate mortality of patients with disseminated non-tuberculous mycobacterial (NTM) disease in Brazil. This diagnosis was neglected in 44.4% of patients, and in-hospital mortality was 41.7%.